Morbid obesity is treated with surgery due to the risks of associated diseases, the low risk of the procedures, and the low long term efficacy of medical and dietary treatments.
This surgery is indicated for patients with morbid obesity (BMI> 40) and for patients with severe obesity (BMI 35-40) with associated comorbidities. However, these criteria were established in 1995 in USA and adopted in 2003 by SECO in Spain. Almost 15 years later, with an EPIDEMIC GLOBESITY, with increased security and less aggressive laparoscopic procedures, and the best results of surgical techniques, it is being considered to extend the indications also to patients with BMI 30-35 and comorbidities, especially diabetes, since we know that the risk / benefit ratio in these patients is very favorable.
To indicate the surgical treatment, as a general rule, previous controlled weight loss attempts are needed, age between 18 and 65 years, and the absence of psychiatric illness or severe addictions that may contraindicate surgery.
Surgery may be considered in patients with less overweight if there is medically sufficient reasons for weight reduction and surgery seems to be the only way to get it.
This is major surgery is not cosmetic surgery, and the ultimate goal is not to reach the ideal weight but to improve control of comorbidities that increase the quality of life, reducing the risk of mortality.
We believe that success depends on the operation itself and the subsequent follow up.
The goal of surgery is to control obesity by changing the balance of energy expenditure in two ways: reducing the amount of food we eat, and making food not completely digested and absorbed (partial malabsorption).
Meet the team
